FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Muhammad Khazaeli

Research Profile

Chemicals & Drugs

Procedures

Radioimmunotherapy

Living Beings

Disorders

Anatomy

Tumor Cells, Cultured

Concepts & Ideas

Devices

Radiometry

Co-author Network

Publications

TOP 3
Donald J Buchsbaum; Muhammad B Khazaeli; Axworthy Don; Jody Schultz; Tandra R Chaudhuri; Kurt R Zinn; Mark Carpenter; Albert F LoBuglio
Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
Buck E Rogers; Peter L Roberson; Sui Shen; Muhammad B Khazaeli; Mark Carpenter; Shigeru Yokoyama; Martin W Brechbiel; Albert F LoBuglio; Donald J Buchsbaum
Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.
Andres Forero; Ruby F Meredith; Muhammad B Khazaeli; Sui Shen; William E Grizzle; Delicia Carey; Elizabeth M Busby; Albert F LoBuglio; Francisco Robert
Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Muhammad Khazaeli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Donald J Buchsbaum; Muhammad B Khazaeli; Axworthy Don; Jody Schultz; Tandra R Chaudhuri; Kurt R Zinn; Mark Carpenter; Albert F LoBuglio
Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(22):8180-5.
2005: Buck E Rogers; Peter L Roberson; Sui Shen; Muhammad B Khazaeli; Mark Carpenter; Shigeru Yokoyama; Martin W Brechbiel; Albert F LoBuglio; Donald J Buchsbaum
Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.
Cancer biotherapy & radiopharmaceuticals 2005;20(5):502-13.
2005: Andres Forero; Ruby F Meredith; Muhammad B Khazaeli; Sui Shen; William E Grizzle; Delicia Carey; Elizabeth M Busby; Albert F LoBuglio; Francisco Robert
Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration.
Cancer biotherapy & radiopharmaceuticals 2005;20(5):467-78.
2005: Andres Forero-Torres; Sui Shen; Hazel Breitz; Robert B Sims; Axworthy Don; Muhammad B Khazaeli; Kuang-Ho Chen; Ivor Percent; Stephen Besh; Albert F LoBuglio; Ruby F Meredith
Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein.
Cancer biotherapy & radiopharmaceuticals 2005;20(4):379-90.
2005: Sui Shen; Andres Forero; Albert F LoBuglio; Hazel Breitz; Muhammad B Khazaeli; Darrell R Fisher; Wenquan Wang; Ruby F Meredith
Patient-specific dosimetry of pretargeted radioimmunotherapy using CC49 fusion protein in patients with gastrointestinal malignancies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(4):642-51.
2005: Sui Shen; Ruby F Meredith; Jun Duan; Andres Forero; Hazel Breitz; Muhammad B Khazaeli; Ivan A Brezovich; Albert F LoBuglio
Testicular uptake and radiation dose in patients receiving Zevalin and Pretarget CC49Fusion protein.
Cancer biotherapy & radiopharmaceuticals 2005;20(1):110-8.
2004: Johann S de Bono; Anthony W Tolcher; Andre Forero; Gertrude F A Vanhove; Chris H Takimoto; Robert J Bauer; Lisa A Hammond; Amita Patnaik; Mark L White; Sui Shen; Muhammad B Khazaeli; Eric K Rowinsky; Albert F LoBuglio
ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7555-65.
2004: Ahmad Safavy; Gunda I Georg; David VanderVelde; Kevin P Raisch; Kamellia Safavy; Mark Carpenter; Wenquan Wang; James A. Bonner; Muhammad B Khazaeli; Donald J Buchsbaum
Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.
Bioconjugate chemistry 2004;15(6):1264-74.
2003: Andres Forero; Ruby F Meredith; Muhammad B Khazaeli; D Mark Carpenter; Sui Shen; Jennifer Thornton; Jeffrey Schlom; Albert F LoBuglio
A novel monoclonal antibody design for radioimmunotherapy.
Cancer biotherapy & radiopharmaceuticals 2003;18(5):751-9.
2003: David C Chhieng; Cristina Rodriguez-Burford; Lynya Talley; Helena Sviglin; Cecil R Stockard; Marc J Kleinberg; Mack N Barnes; Edward E Partridge; Muhammad B Khazaeli; William E Grizzle
Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinoma.
Human pathology 2003;34(10):1016-21.
2003: Ruby F Meredith; Sui Shen; Daniel J Macey; Muhammad B Khazaeli; Delicia Carey; Francisco Robert; Albert F LoBuglio
Comparison of biodistribution, dosimetry, and outcome from clinical trials of radionuclide-CC49 antibody therapy.
Cancer biotherapy & radiopharmaceuticals 2003;18(3):393-404.
2003: Sui Shen; Ruby F Meredith; Jun Duan; Ivan A Brezovich; Muhammad B Khazaeli; Albert F LoBuglio
Comparison of methods for predicting myelotoxicity for non-marrow targeting I-131-antibody therapy.
Cancer biotherapy & radiopharmaceuticals 2003;18(2):209-15.
2003: James A Posey; Thian C Ng; Baolian Yang; Muhammad B Khazaeli; Mark D Carpenter; Floyd Fox; Michael Neil Needle; Harlan W Waksal; Albert F LoBuglio
A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1323-32.
2003: Ahmad Safavy; James A. Bonner; Harlan W Waksal; Donald J Buchsbaum; G Yancey Gillespie; Muhammad B Khazaeli; Ramin B Arani; Dung-Tsa Chen; Mark Carpenter; Kevin P Raisch
Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
Bioconjugate chemistry 2003;14(2):302-10.
2003: Rodney R Larson; Muhammad B Khazaeli; H Kenneth Dillon
A new monitoring method using solid sorbent media for evaluation of airborne cyclophosphamide and other antineoplastic agents.
Applied occupational and environmental hygiene 2003;18(2):120-31.
2003: Rodney R Larson; Muhammad B Khazaeli; H Kenneth Dillon
Development of an HPLC method for simultaneous analysis of five antineoplastic agents.
Applied occupational and environmental hygiene 2003;18(2):109-19.
2002: James A Posey; Muhammad B Khazaeli; Michael A Bookman; Anahit Nowrouzi; William E Grizzle; Jennifer Thornton; Delicia E Carey; Jennifer M Lorenz; Amy P Sing; Clay B Siegall; Albert F LoBuglio; Mansoor N Saleh
A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(10):3092-9.
2002: Ronald D Alvarez; Warner K Huh; Muhammad B Khazaeli; Ruby F Meredith; Edward E Partridge; Larry C Kilgore; William E Grizzle; Sui Shen; J Maxwell Austin; Mack N Barnes; Delicia Carey; Jeffrey Schlom; Albert F LoBuglio
A Phase I study of combined modality (90)Yttrium-CC49 intraperitoneal radioimmunotherapy for ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(9):2806-11.
2002: Sui Shen; Ruby F Meredith; Jun Duan; Daniel J Macey; Muhammad B Khazaeli; Francisco Robert; Albert F LoBuglio
Improved prediction of myelotoxicity using a patient-specific imaging dose estimate for non-marrow-targeting (90)Y-antibody therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(9):1245-53.
2002: Rodney R Larson; Muhammad B Khazaeli; H Kenneth Dillon
Monitoring method for surface contamination caused by selected antineoplastic agents.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2002;59(3):270-7.
2001: Ruby F Meredith; Ronald D Alvarez; Edward E Partridge; Muhammad B Khazaeli; C Y Lin; Daniel J Macey; J Maxwell Austin; Larry C Kilgore; William E Grizzle; Jeffrey Schlom; Albert F LoBuglio
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I study.
Cancer biotherapy & radiopharmaceuticals 2001;16(4):305-15.
2001: Francisco Robert; MP Ezekiel; Sharon A Spencer; Ruby F Meredith; James A. Bonner; Muhammad B Khazaeli; Mansoor N Saleh; Delicia Carey; Albert F LoBuglio; Richard H Wheeler; M R Cooper; Harlan W Waksal
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(13):3234-43.
2001: Feng Wang-Johanning; Andra R Frost; Gary L Johanning; Muhammad B Khazaeli; Albert F LoBuglio; Denise R Shaw; Theresa V Strong
Expression of human endogenous retrovirus k envelope transcripts in human breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(6):1553-60.
2001: James A Posey; Muhammad B Khazaeli; A DelGrosso; Mansoor N Saleh; C Y Lin; W Huse; Albert F LoBuglio
A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer.
Cancer biotherapy & radiopharmaceuticals 2001;16(2):125-32.
2000: T A Hampton; Robert M Conry; Muhammad B Khazaeli; Denise R Shaw; David T Curiel; Albert F LoBuglio; Theresa V Strong
SEREX analysis for tumor antigen identification in a mouse model of adenocarcinoma.
Cancer gene therapy 2000;7(3):446-55.
1999: Ahmad Safavy; Kevin P Raisch; Muhammad B Khazaeli; Donald J Buchsbaum; James A. Bonner
Paclitaxel derivatives for targeted therapy of cancer: toward the development of smart taxanes.
Journal of medicinal chemistry 1999;42(23):4919-24.
1999: Lara L Chappell; Buck E Rogers; Muhammad B Khazaeli; MS Mayo; Donald J Buchsbaum; Martin W Brechbiel
Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N',N'',N'''-tri s(acetic acid)cyclododecane (PA-DOTA).
Bioorganic & medicinal chemistry 1999;7(11):2313-20.
1999: Ruby F Meredith; Muhammad B Khazaeli; Daniel J Macey; William E Grizzle; M Mayo; Jeffrey Schlom; Charles D Russell; Albert F LoBuglio
Phase II study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3254s-3258s.
1999: Donald J Buchsbaum; Muhammad B Khazaeli; MS Mayo; Peter L Roberson
Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3153s-3159s.
1999: Donald J Buchsbaum; Buck E Rogers; Muhammad B Khazaeli; MS Mayo; Diane E Milenic; Syed V S Kashmiri; C J Anderson; Lara L Chappell; Martin W Brechbiel; David T Curiel
Targeting strategies for cancer radiotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3048s-3055s.
1999: Ahmad Safavy; Muhammad B Khazaeli; K Safavy; MS Mayo; Donald J Buchsbaum
Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):2994s-3000s.
1999: Robert M Conry; Muhammad B Khazaeli; Mansoor N Saleh; Karen O Allen; Daunte L Barlow; Susan E Moore; D Craig; Ramin B Arani; Jeffrey Schlom; Albert F LoBuglio
Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(9):2330-7.
1999: Ahmad Safavy; Muhammad B Khazaeli; Marion Kirk; Lori Coward; Donald J Buchsbaum
Further studies on the protein conjugation of hydroxamic acid bifunctional chelating agents: group-specific conjugation at two different loci.
Bioconjugate chemistry 1999;10(1):18-23.
1998: Robert M Conry; S A White; Patricia N Fultz; Muhammad B Khazaeli; Theresa V Strong; Karen O Allen; Daunte L Barlow; Susan E Moore; Pat Coan; I Davis; David T Curiel; Albert F LoBuglio
Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(11):2903-12.
1998: Liliana Soroceanu; Y Gillespie; Muhammad B Khazaeli; Harald Sontheimer
Use of chlorotoxin for targeting of primary brain tumors.
Cancer research 1998;58(21):4871-9.
1998: Cynthia M Rodenburg; R Mernaugh; Guadalupe Bilbao; Muhammad B Khazaeli
Production of a single chain anti-CEA antibody from the hybridoma cell line T84.66 using a modified colony-lift selection procedure to detect antigen-positive ScFv bacterial clones.
Hybridoma 1998;17(1):1-8.
1997: Ahmad Safavy; Muhammad B Khazaeli; H Qin; Donald J Buchsbaum
Synthesis of bombesin analogues for radiolabeling with rhenium-188.
Cancer 1997;80(12 Suppl):2354-9.
1997: Buck E Rogers; ME Rosenfeld; Muhammad B Khazaeli; Galina Mikheeva; Murray A Stackhouse; T Liu; David T Curiel; Donald J Buchsbaum
Localization of iodine-125-mIP-Des-Met14-bombesin (7-13)NH2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(8):1221-9.
1997: ME Rosenfeld; Buck E Rogers; Muhammad B Khazaeli; Galina Mikheeva; D Raben; M S Mayo; David T Curiel; Donald J Buchsbaum
Adenoviral-mediated delivery of gastrin-releasing peptide receptor results in specific tumor localization of a bombesin analogue in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(7):1187-94.
1997: T Liu; Ruby F Meredith; Mansoor N Saleh; Richard H Wheeler; Muhammad B Khazaeli; W E Plott; Jeffrey Schlom; Albert F LoBuglio
Correlation of toxicity with treatment parameters for 131I-CC49 radioimmunotherapy in three phase II clinical trials.
Cancer biotherapy & radiopharmaceuticals 1997;12(2):79-87.
1997: Ronald D Alvarez; Edward E Partridge; Muhammad B Khazaeli; G Plott; M Austin; Larry C Kilgore; Charles D Russell; T Liu; William E Grizzle; Jeffrey Schlom; Albert F LoBuglio; Ruby F Meredith
Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study.
Gynecologic oncology 1997;65(1):94-101.
1996: Donald J Buchsbaum; David Raben; Murray A Stackhouse; Muhammad B Khazaeli; Buck E Rogers; M E Rosenfeld; T Liu; David T Curiel
Approaches to enhance cancer radiotherapy employing gene transfer methods.
Gene therapy 1996;3(12):1042-68.
1996: Ruby F Meredith; Muhammad B Khazaeli; W E Plott; William E Grizzle; T Liu; Jeffrey Schlom; Charles D Russell; Richard H Wheeler; Albert F LoBuglio
Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(11):1811-8.
1996: Ruby F Meredith; Edward E Partridge; Ronald D Alvarez; Muhammad B Khazaeli; G Plott; Charles D Russell; Richard H Wheeler; T Liu; William E Grizzle; Jeffrey Schlom; Albert F LoBuglio
Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(9):1491-6.
1996: David Raben; Donald J Buchsbaum; Muhammad B Khazaeli; M E Rosenfeld; G Yancey Gillespie; W E Grizzle; T Liu; David T Curiel
Enhancement of radiolabeled antibody binding and tumor localization through adenoviral transduction of the human carcinoembryonic antigen gene.
Gene therapy 1996;3(7):567-80.
1995: Ruby F Meredith; Muhammad B Khazaeli; W E Plott; S A Spencer; Richard H Wheeler; L W Brady; D V Woo; Albert F LoBuglio
Initial clinical evaluation of iodine-125-labeled chimeric 17-1A for metastatic colon cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(12):2229-33.
1995: Donald J Buchsbaum; Muhammad B Khazaeli; T Liu; S Bright; K Richardson; M Jones; Ruby F Meredith
Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
Cancer research 1995;55(23 Suppl):5881s-5887s.
1995: Robert M Conry; Muhammad B Khazaeli; Mansoor N Saleh; V Ghetie; E S Vitetta; T Liu; Albert F LoBuglio
Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administration.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1995;18(4):231-41.
1995: Mansoor N Saleh; Muhammad B Khazaeli; Richard H Wheeler; R P Bucy; T Liu; MP Everson; David H Munn; Jeffrey Schlom; Albert F LoBuglio
Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer.
Cancer research 1995;55(19):4339-46.
1994: H Schmitt; Muhammad B Khazaeli; Cynthia M Rodenburg; S Kaul; G Bastert
Production of mouse monoclonal anti-idiotypic antibodies specific to epitopes of tumor-associated mucin TAG-12.
Hybridoma 1994;13(5):389-96.
1994: Ruby F Meredith; Anton J Bueschen; Muhammad B Khazaeli; W E Plott; William E Grizzle; Richard H Wheeler; Jeffrey Schlom; Charles D Russell; T Liu; Albert F LoBuglio
Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(6):1017-22.
1994: Donald J Buchsbaum; Muhammad B Khazaeli; Mary A Davis; Theodore S Lawrence
Sensitization of radiolabeled monoclonal antibody therapy using bromodeoxyuridine.
Cancer 1994;73(3 Suppl):999-1005.
1994: Muhammad B Khazaeli; Robert M Conry; Albert F LoBuglio
Human immune response to monoclonal antibodies.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;15(1):42-52.
1993: Mansoor N Saleh; Muhammad B Khazaeli; William E Grizzle; Richard H Wheeler; S Lawson; T Liu; C Russel; Ruby F Meredith; Jeffrey Schlom; Albert F LoBuglio
A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancer.
Cancer research 1993;53(19):4555-62.
1993: Ruby F Meredith; Muhammad B Khazaeli; William E Grizzle; R A Orr; G Plott; M M Urist; T Liu; Charles D Russell; Richard H Wheeler; Jeffrey Schlom
Direct localization comparison of murine and chimeric B72.3 antibodies in patients with colon cancer.
Human antibodies and hybridomas 1993;4(4):190-7.
1993: A M Cartner; Robert M Conry; Ahmad Safavy; Muhammad B Khazaeli; L A Sumerel; Albert F LoBuglio
An animal model to predict the immunogenicity of murine V regions in humans.
Human antibodies and hybridomas 1993;4(4):174-80.
1993: Mansoor N Saleh; J D Stapleton; Muhammad B Khazaeli; Albert F LoBuglio
Generation of a human anti-idiotypic antibody that mimics the GD2 antigen.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(6):3390-8.
1993: Ahmad Safavy; Donald J Buchsbaum; Muhammad B Khazaeli
Synthesis of N-[tris[2-[[N-(benzyloxy)amino]carbonyl]ethyl]methyl]succinamic acid, trisuccin. Hydroxamic acid derivatives as a new class of bifunctional chelating agents.
Bioconjugate chemistry 1993;4(3):194-8.
1992: Robert M Conry; Muhammad B Khazaeli; Albert F LoBuglio
Lack of T-cell immunity in humans with preexisting anti-mouse immunoglobulin reactivity.
Cancer research 1992;52(24):6979-82.
1992: Ruby F Meredith; Muhammad B Khazaeli; T Liu; G Plott; Richard H Wheeler; C Russell; David Colcher; Jeffrey Schlom; D Shochat; Albert F LoBuglio
Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(9):1648-53.
1992: Mansoor N Saleh; Muhammad B Khazaeli; Richard H Wheeler; E Dropcho; T Liu; M Urist; D M Miller; S Lawson; P Dixon; C H Russell
Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma.
Cancer research 1992;52(16):4342-7.
1992: Muhammad B Khazaeli; Mansoor N Saleh; T Liu; P M Kaladas; S C Gilman; A F LoBuglio
Frequent anti-V-region immune response to mouse B72.3 monoclonal antibody.
Journal of clinical immunology 1992;12(2):116-21.
1992: G C Wolf; F W Byrn; T S McConnell; Muhammad B Khazaeli
Amniotic fluid levels of human chorionic gonadotropin and its alpha and beta subunits in second-trimester chromosomally abnormal pregnancies.
Prenatal diagnosis 1992;12(2):93-101.
1992: Ruby F Meredith; Muhammad B Khazaeli; W E Plott; Mansoor N Saleh; T Liu; L F Allen; Charles D Russell; R A Orr; David Colcher; Jeffrey Schlom
Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(1):23-9.
1992: Mansoor N Saleh; Muhammad B Khazaeli; Richard H Wheeler; L Allen; A B Tilden; W Grizzle; R A Reisfeld; Alice L Yu; S D Gillies; A F LoBuglio
Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma.
Human antibodies and hybridomas 1992;3(1):19-24.
1991: Muhammad B Khazaeli; Mansoor N Saleh; T P Liu; Ruby F Meredith; Richard H Wheeler; T S Baker; D King; D Secher; L Allen; K Rogers
Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans.
Cancer research 1991;51(20):5461-6.
1991: Mansoor N Saleh; Richard H Wheeler; J Y Lee; Muhammad B Khazaeli; M W Unger; C H Russell; A F LoBuglio
In-111 labeled monoclonal anti-carcinoembryonic antigen antibody (ZCE025) in the immunoscintigraphic imaging of metastatic antigen-producing adenocarcinomas.
Clinical nuclear medicine 1991;16(2):110-6.
1990: Charles J Fisher; J Zimmerman; Muhammad B Khazaeli; Timothy E Albertson; R Phillip Dellinger; Edward A Panacek; G E Foulke; C Dating; C R Smith; A F LoBuglio
Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndrome.
Critical care medicine 1990;18(12):1311-5.
1990: J M Trang; A F LoBuglio; Richard H Wheeler; E B Harvey; L Sun; J Ghrayeb; Muhammad B Khazaeli
Pharmacokinetics of a mouse/human chimeric monoclonal antibody (C-17-1A) in metastatic adenocarcinoma patients.
Pharmaceutical research 1990;7(6):587-92.
1990: Muhammad B Khazaeli; R Wheeler; K Rogers; N Teng; E Ziegler; A Haynes; Mansoor N Saleh; J M Hardin; S Bolmer; J Cornett
Initial evaluation of a human immunoglobulin M monoclonal antibody (HA-1A) in humans.
Journal of biological response modifiers 1990;9(2):178-84.
1990: Mansoor N Saleh; A F LoBuglio; Richard H Wheeler; K J Rogers; A Haynes; J Y Lee; Muhammad B Khazaeli
A phase II trial of murine monoclonal antibody 17-1A and interferon-gamma: clinical and immunological data.
Cancer immunology, immunotherapy : CII 1990;32(3):185-90.
1990: J M Hardin; Muhammad B Khazaeli; I E Allen; C Dating; A F LoBuglio
Limited sampling models for HA-1A IgM monoclonal antibody.
Human antibodies and hybridomas 1990;1(2):115-9.
1989: A F LoBuglio; Richard H Wheeler; J Trang; A Haynes; K Rogers; E B Harvey; L Sun; J Ghrayeb; Muhammad B Khazaeli
Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(11):4220-4.
1989: M Frontiera; James L Murray; L Lamki; J Thomas; W Satterlee; R Schmelter; Michael G Rosenblum; Muhammad B Khazaeli; M W Unger; William A Robinson
Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanoma.
Clinical nuclear medicine 1989;14(5):357-66.
1989: Muhammad B Khazaeli
Quantitation of mouse monoclonal antibody and human anti-mouse antibody response in serum of patients.
Hybridoma 1989;8(2):231-9.
1989: Muhammad B Khazaeli; E S Buchina; R A Pattillo; S J Soong; K D Hatch
Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
American journal of obstetrics and gynecology 1989;160(2):444-9.
1988: D R Shaw; Muhammad B Khazaeli; A F LoBuglio
Mouse/human chimeric antibodies to a tumor-associated antigen: biologic activity of the four human IgG subclasses.
Journal of the National Cancer Institute 1988;80(19):1553-9.
1988: Muhammad B Khazaeli; Mansoor N Saleh; Richard H Wheeler; W J Huster; H Holden; R Carrano; A F LoBuglio
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune response.
Journal of the National Cancer Institute 1988;80(12):937-42.
1988: A F LoBuglio; Mansoor N Saleh; J Lee; Muhammad B Khazaeli; R Carrano; H Holden; Richard H Wheeler
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. I. Clinical aspects.
Journal of the National Cancer Institute 1988;80(12):932-6.
1988: D R Shaw; M E Conley; F J Knox; Muhammad B Khazaeli; Albert F LoBuglio
Direct quantitation of IgG subclasses 1, 2, and 3 bound to red cells by Rh1 (D) antibodies.
Transfusion 1988;28(2):127-31.
1987: Muhammad B Khazaeli; W H Beierwaltes; G S Pitt; G A Kabza; K J Rogers; A F LoBuglio
Development and characterization of a monoclonal antibody to human embryonal carcinoma.
The Journal of urology 1987;137(6):1295-9.
1986: A F Lobuglio; M Saleh; L Peterson; R Wheeler; R Carrano; W Huster; Muhammad B Khazaeli
Phase I clinical trial of CO17-1A monoclonal antibody.
Hybridoma 1986;5 Suppl 1():S117-23.
1984: R A Pattillo; Muhammad B Khazaeli; A C Ruckert; R O Hussa; B D Collier; W Beierwaltes; R F Mattingly
Choriocarcinoma: blocking factor and monoclonal antibody iodine 131 imaging.
American journal of obstetrics and gynecology 1984;148(7):1040-8.
1984: Muhammad B Khazaeli; L E Brown; G A Kabza; E W Sargent; W H Beierwaltes
Selection of monoclonal antibody to hCG which localizes in human choriocarcinoma growing in the Syrian hamster cheek pouch.
Hybridoma 1984;3(1):41-8.
1981: Muhammad B Khazaeli; B G England; R C Dieterle; G D Nordblom; G A Kabza; W H Beierwaltes
Development and characterization of a monoclonal antibody which distinguishes the beta-subunit of human chorionic gonadotropin (beta hCG) in the presence of the hCG.
Endocrinology 1981;109(4):1290-2.